Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Anas Najjar & Rafik Karaman. (2019) The prodrug approach in the era of drug design. Expert Opinion on Drug Delivery 16:1, pages 1-5.
Read now
Read now
Andrea Angeli, Fabio Vaiano, Francesco Mari, Elisabetta Bertol & Claudiu T. Supuran. (2017) Psychoactive substances belonging to the amphetamine class potently activate brain carbonic anhydrase isoforms VA, VB, VII, and XII. Journal of Enzyme Inhibition and Medicinal Chemistry 32:1, pages 1253-1259.
Read now
Read now
Rakesh Jain & Jeffrey G. Stark. (2016) Safety and efficacy considerations due to misuse of extended-release formulations of stimulant medications. Postgraduate Medicine 128:7, pages 672-681.
Read now
Read now
Ann Childress & Floyd R Sallee. (2013) The use of methylphenidate hydrochloride extended-release oral suspension for the treatment of ADHD. Expert Review of Neurotherapeutics 13:9, pages 979-988.
Read now
Read now
Paul Hodgkins, Ralf W Dittmann, Shaw Sorooshian & Tobias Banaschewski. (2013) Individual treatment response in attention-deficit/hyperactivity disorder: broadening perspectives and improving assessments. Expert Review of Neurotherapeutics 13:4, pages 425-433.
Read now
Read now
Jadwiga Najib. (2012) Lisdexamfetamine in the treatment of adolescents and children with attention-deficit/hyperactivity disorder. Adolescent Health, Medicine and Therapeutics 3, pages 51-66.
Read now
Read now
Articles from other publishers (12)
Stephanie Brandt, Julia Schnurbein, Belinda Lennerz, Katja Kohlsdorf, Heike Vollbach, Christian Denzer, Harald Bode, Johannes Hebebrand & Martin Wabitsch. (2019)
Methylphenidate in children with monogenic obesity due to
LEPR
or
MC4R
deficiency improves feeling of satiety and reduces BMI‐SDS—A case series
. Pediatric Obesity 15:1.
Crossref
Crossref
Arthur Caye, James M. Swanson, David Coghill & Luis Augusto Rohde. (2018) Treatment strategies for ADHD: an evidence-based guide to select optimal treatment. Molecular Psychiatry 24:3, pages 390-408.
Crossref
Crossref
Hyo-Won Kim, Eunjoo Kim, Ji-Hoon Kim, Jangho Park, Geon Ho Bahn, Yeon Jung Lee, Kyungun Jhung & Dongwon Shin. (2017) The Revised Korean Practice Parameter for the Treatment of Attention-Deficit Hyperactivity Disorder (III) - Pharmacological Treatment -. Journal of the Korean Academy of Child and Adolescent Psychiatry 28:2, pages 70-83.
Crossref
Crossref
Sumin Lee, Jae-Won Choi, Kyoung-Min Kim, Jun Won Kim, Sooyeon Kim, Taewoong Kang, Johanna Inhyang Kim, Young Sik Lee, Bongseog Kim, Doug Hyun Han, Jae Hoon Cheong, Soyoung Irene Lee, Gi Jung Hyun & Bung-Nyun Kim. (2016) The Guideline of Diagnosis and Treatment of Attention-Deficit Hyperactivity Disorder: Developed by ADHD Translational Research Center. Journal of the Korean Academy of Child and Adolescent Psychiatry 27:4, pages 236-266.
Crossref
Crossref
Eloisa Comiran, Félix Henrique Kessler, Pedro Eduardo Fröehlich & Renata Pereira Limberger. (2016) Lisdexamfetamine: A pharmacokinetic review. European Journal of Pharmaceutical Sciences 89, pages 172-179.
Crossref
Crossref
David B Clemow & Chris J Bushe. (2015) Atomoxetine in patients with ADHD: A clinical and pharmacological review of the onset, trajectory, duration of response and implications for patients. Journal of Psychopharmacology 29:12, pages 1221-1230.
Crossref
Crossref
Ann C. Childress. 2014. The Encyclopedia of Clinical Psychology. The Encyclopedia of Clinical Psychology
1
6
.
David Coghill, Tobias Banaschewski, Alessandro Zuddas, Antonio Pelaz, Antonella Gagliano & Manfred Doepfner. (2013) Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies. BMC Psychiatry 13:1.
Crossref
Crossref
Sudha R Raman, Stephen W Marshall, Kevin Haynes, Bradley N Gaynes, Albert Jackson Naftel & Til Stürmer. (2013) Stimulant treatment and injury among children with attention deficit hyperactivity disorder: an application of the self-controlled case series study design. Injury Prevention 19:3, pages 164-170.
Crossref
Crossref
Christopher Steer, Jan Froelich, César A. Soutullo, Mats Johnson & Monica Shaw. (2012) Lisdexamfetamine Dimesylate. CNS Drugs 26:8, pages 691-705.
Crossref
Crossref
Chris Chandler. 2010. The Science of ADHD. The Science of ADHD
240
326
.
Diane E. May & Christopher J. Kratochvil. (2010) Attention-Deficit Hyperactivity Disorder. Drugs 70:1, pages 15-40.
Crossref
Crossref